First identified for its potential therapeutic benefits in SMA in Caenorhabditis elegans and Drosophila melanogaster screening studies, 4-AP increased muscle size and improved motor function in flies [134] and increased neuromuscular function and rescued the phenotype of C. elegans SMA mutant models [135]. Here, SMN1 is linked to proximal spinal muscular atrophy.